Good morning, everyone. A spot of rain is falling this morning on the Pharmalot corporate campus, where we are, once again, hustling those short people off to the local schoolhouses. Always a challenge. And, of course, we are quaffing that mandatory cup of stimulation as we ready ourselves for another busy day. We know you can relate. To get your motor going, here are a few items of interest. Hope your day goes well and you accomplish much...
Novartis Shuts Swiss Neuroscience Facility (Nature)
German Court Forces Novartis To Resume Deliveries (Reuters)
Supreme Court Hears Argument Over Generic Clash (Reuters)
Merck To Invest $1.5B In China And Open New R&D HQ (Reuters)
Former Pfizer Employee Gets Probation For Embezzlement (The Day)
Former Football Players Sue NFL Over Painkiller (New York Times)
India To Regulate Prices Of 40 Cancer Meds (Economic Times)
Pfizer Kidney Cancer Drug Effect May Be Limited: FDA Staff (Reuters)
Takeda Plans To Open Global Vaccines Unit (Pharma Times)
Samsung And Biogen Form Biosimilars Joint Venture (InPharma Technologist)
FDA Commish Sees Opportunity In Opening Up Drug Data (Reuters)
Regeneron Eye Drug Fails To Show Benefit Over Lucentis (Reuters)
EDITOR'S NOTE: Please check this post for updates throughout the morning
rain pic thx to sterlic on flickr